Marjorie Green

Marjorie Green currently serves as Senior Vice President and Head of Oncology Development at Merck since April 2023, following a tenure as Senior Vice President and Head of Late Stage Development at Seattle Genetics from October 2020 to March 2023. Prior experience includes various leadership roles at Genentech, where Marjorie focused on oncology product development and led numerous clinical trials, including serving as Global Clinical Lead for the Tecentriq GU Program. Marjorie's medical career began at MD Anderson Cancer Center, where responsibilities included managing clinical operations at the Nellie B. Connally Breast Center and participating in multiple clinical trials as a Medical Oncologist and Associate Professor. Marjorie holds an MD from The University of Texas Medical Branch and a BA from the University of Notre Dame.